Tag: IDXG

Blue Horseshoe Stocks: IDXG Update & More

Interpace Diagnostics Group, Inc. IDXG

We tracked IDXG last week over a couple of stellar sessions that led to a swing of more than 400%, cautioning that a dip-and-rip could be in the cards after seeing such a volatile move to the upside.

That’s exactly what we’ve seen in the past couple of days, as IDXG came down to find support at the .865 level, and in the ensuing three sessions it’s been steadily registering higher highs and higher lows, getting back to 1.25 yesterday (+45%).

We’ll continue to follow this story, which kicked off with the revelation that Aetna would cover Interpace’s ThyraMir™ test for its 46 million insured members. (>>View PR)

Experience Art & Design, Inc. EXAD

We had EXAD tagged in yesterday’s premarket report and this subpenny play produced a moderate run to kick off the session, even as the larger markets were struggling with the Fed rate hike announcement.

From an early low of .0023, the stock took just the first hour of trading to find its way up to a high of .0038, for a 65% pop. IDXG hung around that level until around lunchtime, and it did come back down to its daily low toward the close, so we’ll be looking for the possibility of a rebound.

Catalyst Biosciences, Inc. CBIO

We’re also interested in following the activity of CBIO today, which is gapping up in the premarket to the tune of more than 100% and looks like it could be lining up to have a big day. We’ll want to make sure it holds above its 50DMA (.80) on any pullbacks, but if it can breach past its 200DMA of 1.31, things could get very interesting.

News broke yesterday via an 8-K filing that CBIO had entered into a definitive agreement with Wyeth LLC, (wholly-owned subsidiary of Pfizer Inc.) to transfer exclusive rights to research, develop, manufacture and commercialize Factor VIIa variants, CB 813a and CB 813d, as well as transferring the investigational NDA to CBIO as well. (>>View Filing)


Fresh Options Idea:  Transocean, Inc. RIG $15 and $14.50 Puts

Extended Watchlist:
VCEL, NWBO, BCLI, BPMX, DLOV, PPMT

Blue Horseshoe Stocks: Updates, Bottom-Watcher & More

Updates From Last Week

Interpace Diagnostics Group, Inc. IDXG – We outlined IDXG in Thursday morning’s report, and after witnessing a low of .3619 followed by an excellent 232% pop to 1.20 on that first day, we were optimistic about our chances for seeing more new highs on Friday.

They did come, early on in the session as IDXG ripped to a new high of 1.98, bringing our two-day total observed gain on the stock to a walloping 447%

____

MJP International Ltd. MJPI

After initially alerting this stock on Wednesday at a low of .85, MJPI is another multi-dayrunner that we were tracking into the latter half of last week that ended up setting new highs on Friday.

The stock traded in a range from 1.38 and went as high as 2.02; a 46% intraday push. The new top mark, from our observed low of .85, represented an overall increase of 138% in a span of just three sessions.

Ophthotech Corp. OPHT

OPHT is setting off our bottom alarms in a big way this morning. The stock is getting absolutely massacred in the premarket in the wake of a poor clinical data release today. The stock is falling to record lows, which is always something that causes us to take note.

Whenever a knee-jerk reaction to any news sends a stock barreling down to its lowest prices ever, you can be all but certain that at some point in the near future, there’s going to be a substantial rebound. With that comes bounceplay opportunities- a chance to properly time the eventual recovery for what could be significant gains. That’s why we’re placing OPHT on intensive bottom watch in coming sessions.

Extended Watchlist:
SYRX, MEMP, CALA, NDEV, BTDG, TTCM

Blue Horseshoe Stocks: IDXG, MJPI & More

Interpace Diagnostics Group, Inc. IDXG

We had a few solid performers from yesterday morning’s report, but IDXG was definitely the cream of the crop. We saw a huge initial surge out of the gate followed by a steady ramp-up for the remainder of the session.

From a low of .3619, IDXG traded as high as 1.20, which represents an intraday run of 232% and it occurred on more than eighteen times the 30-day average volume. Not only that, but it managed to close above the dollar mark at 1.01. With price action and momentum like that combined with the fact that we’re seeing another gap-up here in the premarket, we’ll defintiely be on the lookout for further activity today, possibly in the form of a dip-and-rip scenario.

The big move was largely catalyzed by the release of a PR alluding to the fact that Aetna has agreed to cover Interpace’s ThyraMir™ test for all of its 46 million members. (>>View Full PR)

MJP International Ltd. MJPI

MJPI extended its gains yesterday and secured its status as a multi-day runner. We tagged this stock on Wednesday at a low of .85 and witnessed a decent run to 1.18 (+39%). Yesterday we recapped its performance, including the very bullish close and high volume,  and mentioned that a continued run could be in the cards.

We turrned out to be spot on in our assessment, and MJPI persisted in its uptrend, trading up from a morning low of 1.20 and reaching a new high of 1.63. That worked out to an intraday push of 36%, and extended our two-day gains on this play to a highly-respectable 92%

Options Recap

Twitter, Inc. TWTR – After furnishing us with double-bag gains yesterday, our target contracts that we initially put forth last Thursday, the TWTR 01/20 $19 and $20 Calls, recorded some modest intraday gains and added to our cumulative totals.

01/20 $19 Calls – Range: 1.33-1.70 – Max Gain: 28%
01/20 $20 Calls – Range: .94-1.22 – Max Gain: 30%

There is a gap on the TWTR chart that runs from roughly $21-24, and with a 01/20 expiration, we’ll continue to track these options, and if it appears the gap will begin to fill, roll up our strike prices accordingly.
______

Fresh Idea:

Wynn Resorts Ltd. WYNN – We’re looking for a possible recovery play for WYNN in the wake of a damning China UnionPay policy change that implements further restriction of the maximum daily allotment for ATM withdrawals in Macau. With 60% of WYNN’s revenue coming from Macau, the stock got hammered during yesterday’s session.

It appears as if some measure of a recovery will take effect this morning, with the stock gapping up in the premarket, so we’re going to be monitoring the WYNN Weekly $96-98.50 Calls for potential quick-strike trades.

Extended Watchlist:
IMUN, PIOI, LEXG, AXPW, ACNV, MSTX